The store will not work correctly when cookies are disabled.
(E)-1-(furan-2-yl)-3-(4-hydroxy-3-isopropyl-5-((E)-(thiazol-2-ylimino)methyl)phenyl)prop-2-en-1-one
ID: ALA3260651
PubChem CID: 136498894
Max Phase: Preclinical
Molecular Formula: C20H18N2O3S
Molecular Weight: 366.44
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: CC(C)c1cc(/C=C/C(=O)c2ccco2)cc(/C=N/c2nccs2)c1O
Standard InChI: InChI=1S/C20H18N2O3S/c1-13(2)16-11-14(5-6-17(23)18-4-3-8-25-18)10-15(19(16)24)12-22-20-21-7-9-26-20/h3-13,24H,1-2H3/b6-5+,22-12+
Standard InChI Key: KQJBGKSAXADAFB-RIYRHGMWSA-N
Molfile:
RDKit 2D
26 28 0 0 0 0 0 0 0 0999 V2000
8.7566 -10.3015 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.7554 -11.1211 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.4635 -11.5300 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.1731 -11.1206 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.1703 -10.2979 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.4617 -9.8927 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.4592 -9.0755 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
10.8765 -9.8867 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.5857 -10.2926 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
12.2919 -9.8813 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.0371 -10.2138 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
13.5816 -9.6045 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.1704 -8.8983 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.3717 -9.0713 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
9.4633 -12.3472 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.1709 -12.7560 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.1707 -13.5732 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.8783 -13.9819 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
8.0488 -9.8931 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.4629 -13.9816 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.7144 -13.6514 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.1674 -14.2585 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.5759 -14.9664 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.3752 -14.7965 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
7.3411 -10.3019 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.0486 -9.0759 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
6 7 1 0
5 8 1 0
8 9 2 0
9 10 1 0
10 11 2 0
11 12 1 0
12 13 2 0
13 14 1 0
14 10 1 0
3 15 1 0
15 16 2 0
16 17 1 0
17 18 2 0
1 19 1 0
17 20 1 0
20 21 2 0
21 22 1 0
22 23 2 0
23 24 1 0
24 20 1 0
19 25 1 0
19 26 1 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 366.44 | Molecular Weight (Monoisotopic): 366.1038 | AlogP: 5.21 | #Rotatable Bonds: 6 |
Polar Surface Area: 75.69 | Molecular Species: NEUTRAL | HBA: 6 | HBD: 1 |
#RO5 Violations: 1 | HBA (Lipinski): 5 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: 8.80 | CX Basic pKa: 0.28 | CX LogP: 5.11 | CX LogD: 5.09 |
Aromatic Rings: 3 | Heavy Atoms: 26 | QED Weighted: 0.37 | Np Likeness Score: -0.80 |
References
1. Sashidhara KV, Rao KB, Kushwaha V, Modukuri RK, Verma R, Murthy PK.. (2014) Synthesis and antifilarial activity of chalcone-thiazole derivatives against a human lymphatic filarial parasite, Brugia malayi., 81 [PMID:24863844] [10.1016/j.ejmech.2014.05.029] |